Trial Profile
Tolerability and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG in Volunteers With Existing Botulinum Immunity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2021
Price :
$35
*
At a glance
- Drugs Botulism vaccine (Primary)
- Indications Botulism
- Focus Pharmacodynamics
- 01 Feb 2021 Status changed from active, no longer recruiting to completed.
- 22 Jan 2020 Planned End Date changed from 1 Mar 2020 to 1 May 2020.
- 22 Jan 2020 Planned primary completion date changed from 1 Oct 2019 to 1 Apr 2020.